Cano F, García-Velasco J A, Millet A, Remohí J, Simón C, Pellicer A
Instituto Valenciano de Infertilidad, Valencia, Spain.
J Assist Reprod Genet. 1997 May;14(5):254-61. doi: 10.1007/BF02765826.
Our purpose was to assess the endocrine status of women with polycystic ovaries (PCO) undergoing IVF, and to compare oocyte quality with endocrine markers of the syndrome, in an attempt to define a subpopulation with poor quality oocytes.
This was a retrospective study. Patients were first endocrinologically analyzed: serum levels of androgens (T, androstenedione, DHEAS), FSH, and LH as well as glucose and insulin after an oral glucose tolerance test (OGTT) were recorded and are expressed as absolute values and area under the curve (AUC). Subsequently, they were followed over a 2-year period in which patients underwent several attempts of IVF as well as serving as oocyte donors. Patients were divided into three groups: group I (n = 4) was women who displayed embryos unable to implant in 15 IVF cycles and 10 ovum donation cycles in which they served as donors; group II (n = 16) was PCO patients in whom IVF (n = 38) and/or oocyte donation cycles (n = 42) resulted in pregnancies; and group III (n = 13) was IVF patients with normal appearance of the ovaries by ultrasound. The endocrine status was compared with the IVF results.
There was no difference among groups in the endocrinological parameters tested, except for the OGTT which identified women in group I as having higher serum glucose and insulin levels than patients in groups II and III. Similarly, the OGTT showed higher serum glucose values in group II compared to group III. Women in group I were also obese. Patients in group III were older than PCO patients and needed more gonadotropins to reach an ovarian response which resulted in a reduced number of oocytes retrieved. Fertilization was also impaired in group I, in which no pregnancy was recorded.
This study shows that there is a particular subgroup of PCO patients with lower fertilization rates and embryos unable to implant. These patients are obese and nonhyperandrogenic and show derangements of insulin secretion.
我们的目的是评估接受体外受精(IVF)的多囊卵巢(PCO)女性的内分泌状况,并将卵母细胞质量与该综合征的内分泌标志物进行比较,以试图确定卵母细胞质量差的亚组人群。
这是一项回顾性研究。首先对患者进行内分泌分析:记录血清雄激素(睾酮、雄烯二酮、硫酸脱氢表雄酮)、促卵泡生成素(FSH)、促黄体生成素(LH)水平以及口服葡萄糖耐量试验(OGTT)后的血糖和胰岛素水平,并以绝对值和曲线下面积(AUC)表示。随后,对她们进行了为期2年的随访,在此期间患者进行了多次IVF尝试以及作为卵母细胞捐赠者。患者分为三组:第一组(n = 4)是在15个IVF周期和10个作为捐赠者的卵子捐赠周期中出现胚胎无法着床的女性;第二组(n = 16)是PCO患者,其IVF(n = 38)和/或卵子捐赠周期(n = 42)导致了妊娠;第三组(n = 13)是超声检查卵巢外观正常的IVF患者。将内分泌状况与IVF结果进行比较。
除OGTT外,所检测的内分泌参数在各组之间没有差异,OGTT显示第一组女性的血清葡萄糖和胰岛素水平高于第二组和第三组患者。同样,OGTT显示第二组的血清葡萄糖值高于第三组。第一组女性也肥胖。第三组患者比PCO患者年龄大,需要更多的促性腺激素才能达到卵巢反应,这导致获取的卵母细胞数量减少。第一组的受精也受到损害,该组未记录到妊娠。
本研究表明,存在一个特定的PCO患者亚组,其受精率较低且胚胎无法着床。这些患者肥胖且无高雄激素血症,并表现出胰岛素分泌紊乱。